Active ingredient
Bromocriptine
10 finished FDA listings contain Bromocriptine as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- BROMOCRIPTINE MESYLATE
- Dosage forms
- Capsule, Tablet
- Routes
- Oral
- Manufacturers / labelers
- 9
- Strengths listed
- .8 mg/1 · 2.5 mg/1 · 5 mg/1
- Brand names in FDA listings
- Cycloset
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1760
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 017962 | ESJAY PHARMA | 1978-06-28 | 3 |
| ANDA 074631 | SANDOZ | 1998-01-13 | 1 |
| ANDA 077226 | MYLAN | 2005-04-04 | 1 |
| ANDA 078899 | ZYDUS PHARMS USA INC | 2008-07-30 | 2 |
| ANDA 077646 | PADAGIS US | 2008-10-01 | 2 |
| NDA 020866 | VEROSCIENCE | 2009-05-05 | 1 |
Official labeling on DailyMed
- BROMOCRIPTINE MESYLATE CAPSULE [ZYDUS PHARMACEUTICALS USA INC.] · version 14 · 2026-08-03
- BROMOCRIPTINE MESYLATE TABLET BROMOCRIPTINE MESYLATE CAPSULE [ANI PHARMACEUTICALS, INC.] · version 4 · 2026-07-30
- BROMOCRIPTINE MESYLATE CAPSULE [MYLAN PHARMACEUTICALS INC.] · version 12 · 2026-06-19
- BROMOCRIPTINE MESYLATE TABLET [AMERICAN HEALTH PACKAGING] · version 2 · 2026-06-15
- BROMOCRIPTINE MESYLATE TABLET [REMEDYREPACK INC.] · version 1 · 2026-04-28
- CYCLOSET (BROMOCRIPTINE MESYLATE) TABLET [AVVISTO THERAPEUTICS LLC] · version 7 · 2026-01-14
- BROMOCRIPTINE MESYLATE CAPSULE [ZYDUS LIFESCIENCES LIMITED] · version 10 · 2024-12-02
- BROMOCRIPTINE MESYLATE TABLET [PADAGIS US LLC] · version 10 · 2024-11-25
- BROMOCRIPTINE MESYLATE TABLET [SANDOZ INC] · version 10 · 2024-10-24
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.